-
Substance use and STI acquisition: Secondary analysis from the AWARE study.
Feaster DJ, Parish CL, Gooden L, Matheson T, Castellon PC, Duan R, Pan Y, Haynes LF, Schackman BR, Malotte CK, Mandler RN, Colfax GN, Metsch LR. Substance use and STI acquisition: Secondary analysis from the AWARE study. Drug and Alcohol Dependence 2016;169:171-179.
-
Psychosocial relationship status and quality as predictors of intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study.
Trombello JM, Carmody T, Greer TL, Walker NR, Rethorst C, Trivedi MH. Psychosocial relationship status and quality as predictors of intervention adherence and substance use outcomes: Results from the STRIDE (CTN-0037) study. Psychiatry Research 2017;254:332-339.
-
Recent internet use and associations with clinical outcomes among patients entering addiction treatment involved in a web-delivered psychosocial intervention study.
Tofighi B, Campbell ANC, Pavlicova M, Hu M, Lee JD, Nunes EV. Recent internet use and associations with clinical outcomes among patients entering addiction treatment involved in a web-delivered psychosocial intervention study. Journal of Urban Health 2016;93(5):871-883.
-
Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial.
Levesque A, Campbell ANC, Pavlicova M, Hu M, Walker NR, McClure EA, Ghitza UD, Bailey GL, Stitzer ML, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addictive Behaviors 2016;65:74-80.
-
Qualitative and quantitative feedback following workshop training in evidence-based practices: A dissemination study.
Houck JM, Forcehimes AA, Davis MMA, Bogenschutz MP. Qualitative and quantitative feedback following workshop training in evidence-based practices: A dissemination study. Professional Psychology: Research and Practice 2016;47(6):413-417.
-
Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for substance use screening in primary care patients.
McNeely J, Wu L, Subramaniam GA, Sharma G, Cathers LA, Svikis DS, Sleiter L, Russell L, Nordeck C, Sharma A, O'Grady KE, Bouk LB, Cushing C, King J, Wahle A, Schwartz RP. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for substance use screening in primary care patients. Annals of Internal Medicine 2016;165(10):690-699.
-
Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders.
Warden D, Sanchez K, Greer TL, Carmody T, Walker NR, dela Cruz AM, Toups M, Rethorst C, Trivedi MH. Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Research 2016;246:136-141.
-
Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence.
Nunes EV, Lee JD, Sisti D, Segal A, Caplan A, Fishman MJ, Bailey GL, Brigham GS, Novo P, Farkas S, Rotrosen J. Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence. Contemporary Clinical Trials 2016;51:34-43.
-
Barriers and facilitators to tobacco cessation in a nationwide sample of addiction treatment programs.
Pagano A, Tajima BM, Guydish JR Barriers and facilitators to tobacco cessation in a nationwide sample of addiction treatment programs. Journal of Substance Abuse Treatment 2016;67:22-29.
-
Smoking among patients in substance use disorders treatment: Associations with tobacco advertising, anti-tobacco messages, and perceived health risks.
Campbell BK, Le T, Andrews KB, Pramod S, Guydish JR. Smoking among patients in substance use disorders treatment: Associations with tobacco advertising, anti-tobacco messages, and perceived health risks. American Journal of Drug and Alcohol Abuse 2016;42(6):649-656.